Key Institutional Policies
- No Retaliation Policy
- Biosafety Levels for Human Research Involving Cell Lines
- Use of Controlled Substances in Research
Midwest Clinical Research Policies
-
Adverse & Serious Adverse Events and Unanticipated Problems Standard Operating Procedure (Enterprise)
Learn More -
Clinical Research Standard Operating Procedure on Standard Operating Procedures Policy (Enterprise)
Learn More -
Essential Records (Enterprise)
Learn More -
Federal Inspection, Regulatory, Sponsor, and Internal Audits Policy (Enterprise)
Learn More -
Honest Broker Certification for Research Policy (Enterprise)
Learn More -
Informed Consent Policy (Enterprise)
Learn More -
IRB Submissions Policy (Enterprise)
Learn More -
Subject Screening and Enrollment Policy (Enterprise)
Learn More
Southeast Clinical Research Policies
-
Adverse & Serious Adverse Events and Unanticipated Problems Standard Operating Procedure (Enterprise)
Learn More -
Clinical Research Standard Operating Procedure on Standard Operating Procedures Policy (Enterprise)
Learn More -
Essential Records (Enterprise)
Learn More -
Federal Inspection, Regulatory, Sponsor, and Internal Audits Policy (Enterprise)
Learn More -
Honest Broker Certification for Research Policy (Enterprise)
Learn More -
Informed Consent Policy (Enterprise)
Learn More -
IRB Submissions Policy (Enterprise)
Learn More -
Subject Screening and Enrollment Policy (Enterprise)
Learn More
Interdisciplinary Policies
Sponsored Programs Policies
- Study/Project Closeout Standard Operating Procedure
- Timeline for Establishing New Chartfields for Newly Sponsored Awards
- Residual Funds Policy
- Proposal Submission Deadline Policy
- Effort Certification Policy
- Establishing Clinical Trials Accounts
- Financial Management of Activities Related to Research
- Graduate Student Tuition on Sponsored Projects
- Cost Sharing Policy
- Cost Transfer Policy